Drugmaker Discloses Fees Paid for Studies to Potentially Help GlaxoSmithKline Sales


. By Charles Benson

After criticism was leveled recently saying that GlaxoSmithKline sales were boosted by fees given to US doctors for studies on the company's medications, the drugmaker recently disclosed the amount paid to physicians and institutions during 2010.

The Wall Street Journal reports that GlaxoSmithKline paid $85 million for work on clinical trials, speaking and consulting, while Pfizer Inc. reportedly paid $177 million.

Criticism against the drugmakers has claimed that the payments influence the doctors to prescribe their drugs more often and potentially promote unapproved uses for certain medications, according to the news source.

The drugmakers, however, claim that such funding is necessary to ensure that research is conducted and that doctors become educated about the approved uses of their medications.

Under the US healthcare overhaul legislation last year, all drugmakers will be required to report data on physician payments to the government starting in 2013, according to the news provider.

GlaxoSmithKline reportedly paid $28.5 million to a variety of institutions associated with 127 total studies in 2010, reports the Journal.


GSK Sales Rep New York Overtime Legal Help

If you or a loved one have suffered losses in this case, please click the link below and your complaint will be sent to a drugs & medical lawyer who may evaluate your GSK Sales Rep New York Overtime claim at no cost or obligation.